VIA
BLTE

Virtus Investment Advisers’s Belite Bio BLTE Stock Holding History

Virtus Investment Advisers’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
2,369
+440
+23% +$67.4K 0.09% 331
2026
Q1 		$308K Buy
1,929
+47
+2% +$7.9K 0.08% 273
2025
Q4 		$301K Buy
1,882
+51
+3% +$6.04K 0.08% 255
2025
Q3 		$135K Buy
1,831
+318
+21% +$20.9K 0.04% 393
2025
Q2 		$87.3K Sell
1,513
-1,076
-42% -$65.6K 0.03% 394
2025
Q1 		$171K Buy
+2,589
New +$156K 0.05% 283

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtus Investment Advisers's BLTE Position: Q2 2026 in Review

Virtus Investment Advisers increased its Belite Bio (BLTE) stake by 23% in Q2 2026, buying an estimated $67.4K and bringing the position to 2,369 shares worth $365K. The position accounts for 0.09% of the portfolio, ranked #331.

Virtus Investment Advisers first reported a position in BLTE in Q1 2025 and has held it in 6 quarters since. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Virtus Investment Advisers held 2,369 shares of Belite Bio worth $365K as of Q2 2026.
  • Virtus Investment Advisers bought 440 Belite Bio shares in Q2 2026, an estimated $67.4K.
  • Belite Bio made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #331 holding.
  • Virtus Investment Advisers first reported a position in Belite Bio in Q1 2025 and has held it in 6 quarters since.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.